One possible biological mechanism of the currently observed association of dMPA exposure with cerebral meningioma could be related to an increased meningioma growth from the presence of medroxyprogesterone acetate and its interaction with the progesterone receptors on the meningioma. The gene discussed is PGR; the disease is meningioma.